《滬深兩市》上證深成創板半日跌0.2%-0.5% 航運股走弱 半導體股回升
人行今日開展100億元人民幣(下同)7天期逆回購操作，今日有100億元逆回購到期；中標利率2.2%持平。人幣中間價下調155點。上證低開低走，深成創板低開後反覆偏軟。
上證指數半日跌17點或0.5%，收報3,521點，成交額2,598億元；深證成指跌62點或0.4%，報14,930點，成交額3,416.5億元。滬深300指數跌26點或0.5%，報5,087點；創業板指微跌7點或0.2%，收報3,442點，成交額1,370億元。
中資金融股偏軟，工行(601398.SH)、建行(601939.SH)分別跌0.4%、0.5%。
港口航運股持續走弱，中遠海特(600428.SH)挫9.3%。盛航股份(001205.SZ)、中遠海控(601919.SH)、寧波海運(600798.SH)、中遠海發(601866.SH)升2.8%-4.3%。
稀土股走高，英威騰(002334.SZ)漲停。川能動力(000155.SZ)揚7.8%。廈門鎢業(600549.SH)上半年淨利潤按年增193%，股價升4.6%。
鋰電股低開高走，國民技術(300077.SZ)、維科技術(600152.SH)、延安必康(002411.SZ)漲停。恩捷股份(002812.SZ)揚6.6%。
半導體股回升，易事特(300376.SZ)、斯達半導(603290.SH)、聚燦光電(300708.SZ)揚6.6%-13.2%。
白酒股繼續有資金吸納，青海春天(600381.SH)漲停。金種子酒(600199.SH)、衆興菌業(002772.SZ)、廣譽遠(600771.SH)升6.5%-8.9%。
醫藥生物、醫美概念股造好，博雅生物(300294.SZ)、未名醫藥(002581.SZ)漲停。哈藥股份(600664.SH)、共同藥業(300966.SZ)、舒泰神(300204.SZ)升5.4%-9.9%。景峯醫藥(000908.SZ)、東寶生物(300239.SZ)、金髮拉比(002762.SZ)升3%-7.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
